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(Gynecol Oncol. 2014; 132: 434–437)Dear Dr. Karlan,
I was interested to read the article by Lachiewicz and colleagues that
appeared in a recent issue of Gynecologic Oncology (Lachiewicz et al.,
2014). The authors conducted a retrospective chart review of patients
with Lynch syndrome who had undergone surgery (hysterectomy
and/or bilateral salpingo-oophorectomy); their purpose was to deter-
mine the prevalence of occult malignancy found during operative man-
agement of these patients. The study revealed that occult malignancy
was found in 17% of Lynch syndrome patients who had undergone sur-
gery for prophylactic indications, and in 26% of Lynch syndrome pa-
tients who had undergone surgery for any indication.
Lachiewicz and colleagues state that theirs was the ﬁrst study to de-
scribe the prevalence of occult malignancy at the time of risk reducing
or nonprophylactic surgery in Lynch syndrome. However, our group pub-
lished similar ﬁndings (Karamurzin et al., 2013) before Lachiewicz's arti-
cle was submitted for publication in Gynecologic Oncology. Like
Lachiewicz's work, ours was focused on determining the prevalence of
carcinoma and atypical hyperplasia at the time of risk reducing surgery
for Lynch syndrome. Our results were similar to those described by
Lachiewicz et al.: in Lynch syndromepatientswhounderwenthysterecto-
my/bilateral salpingo-oophorectomy, incidental endometrial carcinomahttp://dx.doi.org/10.1016/j.gore.2014.10.005
2352-5789/© 2014 The Author. Published by Elsevier Inc. This is an open access article under tand/or endometrial hyperplasia was found in 24% of cases, and ovarian
carcinoma in 4%. Other groups have published on this topic as well,
e.g., Schmeler et al. in 2006 (Schmeler et al., 2006), as noted by
Lachiewicz.
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